Variant report

Variant	nsv962271
Chromosome Location	chr17:16912264-16922846
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr17:16919559-16919741	K562	blood:	n/a	n/a
2	BATF	chr17:16919876-16920187	GM12878	blood:	n/a	chr17:16920025-16920034
3	BATF	chr17:16919900-16920207	GM12878	blood:	n/a	chr17:16920025-16920034
4	BHLHE40	chr17:16919702-16919703	K562	blood:	n/a	n/a
5	BRCA1	chr17:16918354-16918528	Hela-S3	cervix:	n/a	n/a
6	BRCA1	chr17:16914461-16914500	Hela-S3	cervix:	n/a	n/a
7	CEBPB	chr17:16918640-16918890	IMR90	lung:	n/a	chr17:16918744-16918755
8	CEBPB	chr17:16918561-16918935	Hela-S3	cervix:	n/a	chr17:16918744-16918755
9	CEBPB	chr17:16913415-16913587	HepG2	liver:	n/a	n/a
10	CEBPB	chr17:16914359-16914611	HCT-116	colon:	n/a	n/a
11	CEBPB	chr17:16918571-16918888	A549	lung:	n/a	chr17:16918744-16918755
12	CEBPB	chr17:16913388-16913615	A549	lung:	n/a	n/a
13	CEBPB	chr17:16914018-16914047	Hela-S3	cervix:	n/a	n/a
14	CEBPB	chr17:16914303-16914589	A549	lung:	n/a	n/a
15	CEBPB	chr17:16918620-16918806	H1-hESC	embryonic stem cell:	n/a	chr17:16918744-16918755
16	CEBPB	chr17:16914296-16914545	K562	blood:	n/a	n/a
17	CEBPB	chr17:16914372-16914599	HCT-116	colon:	n/a	n/a
18	CEBPB	chr17:16914327-16914513	K562	blood:	n/a	n/a
19	CEBPB	chr17:16914286-16914659	IMR90	lung:	n/a	n/a
20	CEBPB	chr17:16913411-16913619	Hela-S3	cervix:	n/a	n/a
21	CEBPB	chr17:16918015-16918291	Hela-S3	cervix:	n/a	n/a
22	CEBPB	chr17:16914384-16914558	K562	blood:	n/a	n/a
23	CEBPB	chr17:16918593-16918891	HepG2	liver:	n/a	chr17:16918744-16918755
24	CEBPB	chr17:16914285-16914672	Hela-S3	cervix:	n/a	n/a
25	CEBPB	chr17:16918648-16918848	K562	blood:	n/a	chr17:16918744-16918755
26	CHD2	chr17:16914477-16914667	Hela-S3	cervix:	n/a	n/a
27	CHD2	chr17:16917983-16918354	Hela-S3	cervix:	n/a	n/a
28	CTCF	chr17:16913320-16913470	RPTEC	kidney:	n/a	n/a
29	CTCF	chr17:16913300-16913450	SK-N-SH_RA	brain:	n/a	n/a
30	CTCF	chr17:16913344-16913550	SK-N-SH	brain:	n/a	chr17:16913485-16913503
31	CTCF	chr17:16913433-16913531	GM20000	blood:	n/a	chr17:16913485-16913503
32	CTCF	chr17:16913320-16913470	AG04450	lung:	n/a	n/a
33	CTCF	chr17:16913391-16913572	GM13977	blood:	n/a	chr17:16913485-16913503
34	CTCF	chr17:16913377-16913585	GM19239	blood:	n/a	chr17:16913485-16913503
35	CTCF	chr17:16917997-16918083	H1-hESC	embryonic stem cell:	n/a	n/a
36	CTCF	chr17:16913320-16913470	GM06990	blood:	n/a	n/a
37	CTCF	chr17:16913364-16913601	MCF-7	breast:	n/a	chr17:16913485-16913503
38	CTCF	chr17:16913300-16913450	HCFaa	heart:	n/a	n/a
39	CTCF	chr17:16913188-16913756	A549	lung:	n/a	chr17:16913485-16913503
40	CTCF	chr17:16914846-16914920	A549	lung:	n/a	n/a
41	CTCF	chr17:16913363-16913616	GM12891	blood:	n/a	chr17:16913485-16913503
42	CTCF	chr17:16913300-16913450	HMEC	breast:	n/a	n/a
43	CTCF	chr17:16913340-16913490	NHDF-neo	bronchial:	n/a	n/a
44	CTCF	chr17:16913354-16913600	MCF-7	breast:	n/a	chr17:16913485-16913503
45	CTCF	chr17:16914322-16914344	Spleen_OC	spleen:	n/a	n/a
46	CTCF	chr17:16913300-16913450	BJ	skin:	n/a	n/a
47	CTCF	chr17:16913300-16913450	HCT-116	colon:	n/a	n/a
48	CTCF	chr17:16913362-16913585	Lung_OC	lung:	n/a	chr17:16913485-16913503
49	CTCF	chr17:16913365-16913597	Pancreas_OC	pancreas:	n/a	chr17:16913485-16913503
50	CTCF	chr17:16913341-16913699	A549	lung:	n/a	chr17:16913485-16913503

No.	Distal block	Cell Line	Cell type
1	chr17:16917707..16920531-chr17:16944662..16947361,2	MCF-7	breast:
2	chr17:16920975..16923605-chr17:16945817..16947937,2	K562	blood:
3	chr17:16913150..16913949-chr17:16935742..16936397,2	MCF-7	breast:
4	chr17:16922760..16926151-chr17:16927403..16930298,5	K562	blood:
5	chr17:16920777..16926602-chr17:16943525..16948995,8	MCF-7	breast:
6	chr17:16921692..16923812-chr17:17738364..17740042,2	MCF-7	breast:
7	chr17:16922009..16924326-chr17:16949178..16951661,2	MCF-7	breast:
8	chr17:16920470..16922796-chr17:16981423..16984163,2	MCF-7	breast:
9	chr17:16913379..16913893-chr17:17049733..17050556,2	MCF-7	breast:
10	chr17:16921667..16924582-chr17:17139472..17141116,2	MCF-7	breast:
11	chr17:16919740..16922736-chr17:16924450..16926205,2	MCF-7	breast:
12	chr17:16922760..16925384-chr17:16927836..16930121,3	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TNFRSF13B-2	chr17:16915228-16918304	ENSG00000260328.1

Variant related genes	Relation type
ENSG00000260328	TF binding region
ENSG00000133030	chromatin interactions
ENSG00000154803	chromatin interactions
ENSG00000264187	chromatin interactions

Extended variants
information (count: 445 )
Associated
traits (count: 160 )

Variant overlapped rSNPs/rCNVs (count:445 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs527288483	chr17:16912267-16912268	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs142317465	chr17:16912307-16912308	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs560563713	chr17:16912328-16912329	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs569580899	chr17:16912332-16912333	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs180699279	chr17:16912404-16912405	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs151317518	chr17:16912410-16912411	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs371668180	chr17:16912414-16912415	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs3903118	chr17:16912423-16912424	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs117380270	chr17:16912430-16912431	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs566023775	chr17:16912451-16912452	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs186084949	chr17:16912527-16912528	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs201907446	chr17:16912529-16912530	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs554166753	chr17:16912545-16912546	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs567679497	chr17:16912574-16912575	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs536320886	chr17:16912577-16912578	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs556653979	chr17:16912578-16912579	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs576552008	chr17:16912590-16912591	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs7225537	chr17:16912680-16912681	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
19	rs369698195	chr17:16912682-16912683	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs572365451	chr17:16912752-16912753	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs541343556	chr17:16912801-16912802	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs373266525	chr17:16912817-16912818	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs376422162	chr17:16912829-16912830	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs568729876	chr17:16912835-16912836	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs373241202	chr17:16912840-16912841	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs557794760	chr17:16912841-16912842	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs190872132	chr17:16912858-16912859	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs376726967	chr17:16912878-16912879	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs529723710	chr17:16912890-16912891	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs537426121	chr17:16912903-16912904	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs183420027	chr17:16912910-16912911	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs185814908	chr17:16912924-16912925	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs552352114	chr17:16912927-16912928	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs565889709	chr17:16912935-16912936	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs528359959	chr17:16912954-16912955	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs28710838	chr17:16912955-16912956	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs554478558	chr17:16912982-16912983	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs190616008	chr17:16912985-16912986	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs149446320	chr17:16912991-16912992	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs568006887	chr17:16913015-16913016	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs533785259	chr17:16913019-16913020	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs112516982	chr17:16913054-16913055	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs113678834	chr17:16913079-16913080	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs558695054	chr17:16913113-16913114	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs572329606	chr17:16913132-16913133	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs534967744	chr17:16913147-16913148	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs554879178	chr17:16913156-16913157	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs4985776	chr17:16913173-16913174	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs543449431	chr17:16913186-16913187	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs183766464	chr17:16913203-16913204	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:160)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Colorectal cancer	16774939	CNVD
Pancreatic cancer	21811587	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Gastric cancer	18160780	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Breast cancer	21509527	CNVD
Ductal carcinoma	22052326	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	22522925	CNVD
Lung adenocarcinoma	21935476	CNVD

Chromatin state (count:283 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:16903200-16921000	Weak transcription	Lung	lung
2	chr17:16905800-16920000	Weak transcription	Fetal Intestine Large	intestine
3	chr17:16906400-16912600	Weak transcription	Liver	Liver
4	chr17:16906800-16923400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
5	chr17:16909000-16912600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
6	chr17:16909000-16912600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
7	chr17:16909000-16912600	Weak transcription	Osteobl	bone
8	chr17:16909000-16914400	Weak transcription	Fetal Lung	lung
9	chr17:16910800-16913200	Enhancers	A549	lung
10	chr17:16911600-16913800	Enhancers	Hela-S3	cervix
11	chr17:16911800-16912800	Enhancers	NHEK	skin
12	chr17:16911800-16913000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
13	chr17:16911800-16913400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
14	chr17:16911800-16913400	Enhancers	Stomach Mucosa	stomach
15	chr17:16912200-16913400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
16	chr17:16912200-16913400	Enhancers	Skeletal Muscle Male	skeletal muscle
17	chr17:16912200-16913600	Enhancers	Placenta	Placenta
18	chr17:16912200-16913800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
19	chr17:16912200-16913800	Enhancers	HMEC	breast
20	chr17:16912400-16912600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
21	chr17:16912400-16912600	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
22	chr17:16912400-16912800	Enhancers	Placenta Amnion	Placenta Amnion
23	chr17:16912400-16913400	Enhancers	NHDF-Ad	bronchial
24	chr17:16912400-16913600	Enhancers	Pancreas	Pancrea
25	chr17:16912600-16912800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
26	chr17:16912600-16913000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
27	chr17:16912600-16913200	Weak transcription	Duodenum Mucosa	Duodenum
28	chr17:16912600-16913400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
29	chr17:16912600-16913400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
30	chr17:16912600-16913400	Enhancers	HSMMtube	muscle
31	chr17:16912600-16913400	Enhancers	NHLF	lung
32	chr17:16912600-16913400	Enhancers	Osteobl	bone
33	chr17:16912600-16913600	Enhancers	Breast Myoepithelial Primary Cells	Breast
34	chr17:16912600-16914800	Enhancers	Liver	Liver
35	chr17:16912800-16913200	Weak transcription	NHEK	skin
36	chr17:16912800-16914400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
37	chr17:16912800-16917400	Weak transcription	Placenta Amnion	Placenta Amnion
38	chr17:16913000-16913400	Enhancers	Muscle Satellite Cultured Cells	--
39	chr17:16913000-16913400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
40	chr17:16913000-16913400	Enhancers	Fetal Intestine Small	intestine
41	chr17:16913000-16913400	Enhancers	Skeletal Muscle Female	skeletal muscle
42	chr17:16913000-16917400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
43	chr17:16913200-16913400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
44	chr17:16913200-16913400	Enhancers	Duodenum Mucosa	Duodenum
45	chr17:16913200-16913400	Enhancers	Rectal Mucosa Donor 31	rectum
46	chr17:16913200-16913400	Flanking Active TSS	A549	lung
47	chr17:16913200-16913400	Enhancers	NHEK	skin
48	chr17:16913200-16913600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
49	chr17:16913200-16913800	Enhancers	Adipose Nuclei	Adipose
50	chr17:16913200-16913800	Enhancers	HUVEC	blood vessel

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links